Point-of-care diagnostic testing continues expanding well beyond traditional hospital and physician office settings into retail pharmacy clinics and the growing urgent care sector, shifting a meaningful share of diagnostic testing supply demand away from centralized hospital laboratories toward a much more distributed network of smaller-volume testing sites.
What's Driving the Shift
- Patient preference for faster, more convenient testing access, particularly for common respiratory and urinary tract infections where point-of-care results support same-visit treatment decisions
- Continued expansion of CLIA-waived test menus, allowing more test types to be performed in lower-complexity retail and urgent care settings without requiring full laboratory infrastructure
- Payer and health system interest in redirecting lower-acuity diagnostic testing volume away from more expensive hospital-based settings
Supply Chain Implications of Decentralization
Distributors and suppliers serving this growing decentralized market face a genuinely different logistics profile than serving a smaller number of high-volume hospital laboratories — many more delivery points, generally lower order volume per site, and a customer base with less dedicated purchasing and inventory management expertise than a hospital lab typically has.
What This Means for Retail and Urgent Care Operators
Operators scaling point-of-care testing programs across multiple sites benefit from centralizing purchasing and standardizing test menus across locations, capturing purchasing leverage and inventory management efficiency that a fragmented, site-by-site ordering approach leaves on the table as the network grows.
Facilities and clinics expanding point-of-care testing can review Healix Medical Supply's diagnostic equipment catalog.
